2. Results and Discussion
The retrosynthesis of (
R)-
1 is shown in
Scheme 2. The target molecule (
R)-
1 can be readily obtained from alkene
28 through catalytic hydrogenation reduction. The synthesis of alkene
28 can be achieved through Julia–Kocienski olefination between PT-sulfone
12 and chiral aldehyde
13. The synthesis of PT-sulfone
12 can be accomplished by isobutyl bromide
25 in a two-step process involving the Mitsunobu reaction [
14] and subsequent oxidation. Chiral aldehyde
13 can be synthesized from olefin
14 via both catalytic hydrogenation and oxidation processes. Olefin
14 was synthesized via Julia–Kocienski olefination using BT-sulfone
15 and aldehyde
10 as starting materials. BT-sulfone
15 can still be synthesized from chiral alcohol
20 through a two-step process involving the Mitsunobu reaction and oxidation. The synthesis of chiral alcohol
20 can be accomplished via a four-step process starting from 4-benzyloxybutyric acid
16 [
15], with the pivotal step being the asymmetric chiral induction using Evans’ template [
16].
The synthesis of the key intermediates of
13 is shown in
Scheme 3. The compound
18 was synthesized by reacting Evans’ template
17 with acid
16 in the presence of piavloyl chloride [
17], triethylamine, and LiCl [
18], resulting in a yield of 89%. This suggests that LiCl exhibits commendable catalytic activity in the acylation reaction, and the role of LiCl is to form intermediates with a complex structure with the components participating in the reaction. The desired compound
19 was obtained in 75% yield through deprotonation of
18 with NaHMDS, followed by highly diastereoselective alkylation of the resulting chiral imide enolate with MeI at a low temperature. Due to the highly efficient alkali catalytic properties of NaHMDS, its reaction activity and deprotonation ability are enhanced at elevated temperatures. However, conducting the reaction at a low temperature is advantageous for achieving a higher yield of the target product
19 while minimizing the formation of undesired byproducts [
19]. The enantiomeric excess (ee) of the product
19 was determined to be 99% using high-performance liquid chromatography (HPLC) with a chiral AD-H column. Subsequently, compound
19 was treated with LiAlH
4 in dry THF to afford the desired primary alcohol
20, which possessed a chiral center, in a yield of 90%. Next, the chiral alcohol
20 was effectively converted into thioether
22 in the presence of PPh
3 and DIAD via the Mitsunobu reaction with MBT
21 in a 90% yield [
14]. The mechanism of the Mitsunobu reaction is illustrated in
Scheme 3. Initially, triphenylphosphine (PPh
3) undergoes a reaction with diisopropyl azodicarboxylate (DIAD), leading to the formation of an active intermediate. This intermediate subsequently abstracts a proton from mercaptan
21, while alcohol
20 attacks the phosphine cationic center to generate phosphine oxide, and simultaneously, DIAD dissociates as a byproduct of hydrazine. Subsequently, the anions of the nucleophilic mercaptan
21 initiate a reverse attack on the alkylphosphine oxide intermediate, resulting in the formation of the product
22 and the concomitant generation of triphenylphosphine oxide as a byproduct. The enantioselectivity of Evans methylation was determined to be 91:9
er for the derivative
20 through high-performance liquid chromatography (HPLC) analysis on a chiral OD-H column.
Thioether
22 was further oxidized with
m-CPBA to afford sulfone
15 in a high yield of 92% [
20]. Meanwhile, the aldehyde
10 was synthesized following the established protocol in [
11] using 1, 8-octanediol through a two-step procedure. Subsequently, Julia–Kocienski olefination of aldehyde
10 with sulfone
15 deprotonated by NaHMDS resulted in the formation of alkene
14 as a mixture of
Z/
E (3:1, determined from
1H NMR) isomers, with a yield of 63%. Julia–Kocienski olefination [
13] proceeds through a five-membered ring transition state, as depicted in
Scheme 3. Then, alkene
14 was followed by hydrogenation to give compound
23 in a 100% yield using a Pt/C catalyst to avoid racemization of the allylic methyl group [
21]. The compound
23 was subjected to Pd/C catalytic hydrogenation removal of the benzyl protecting group, giving
24 in a 99% yield. The compound
24 was oxidized by PCC dispersed with silicon dioxide to obtain the key intermediate aldehyde
13 with a yield of 82%. Because the addition of silicon dioxide can enhance the adsorption of the byproduct resulting from PCC, the oxidation of compound
24 was better promoted by PCC. This strategy not only enhances reaction efficiency but also mitigates environmental pollution through byproduct adsorption [
22].
As outlined in
Scheme 4, isobutyl bromide
25 was converted into sulfone
12 via
S-alkylation and
m-CPBA/NaHCO
3 oxidation in dry CH
2Cl
2 in a 70% yield over two steps. For the total synthesis of (
R)-
1, compound
28 was first completed using sulfone
12 and chiral aldehyde
13 via Julia–Kocienski olefination in 98% yields, and then further subjected to Pd/C catalytic hydrogenation, giving the target molecule (
R)-
1 in a100% yield. All of the data are consistent with the literature values [
4,
5].
3. Experimental Section
3.1. General Method
All commercially available reagents were used without further purification. THF and diethyl ether were distilled from sodium under argon. Dichloromethane was distilled from calcium hydride under argon. Column chromatography was performed on silica gel (200–400 mesh). The optical rotations were measured using a polarimeter equipped with a sodium lamp. 1H NMR (500 MHz, TMS at δ 0.00 ppm or CDCl3 at δ 7.26 ppm) and 13C NMR (125 MHz, CDCl3 at δ 77.00 ppm as internal standard) spectra were recorded on a Bruker 500 MHz NMR spectrometer. HRMS data were recorded on Thermo Scientific LTQ Orbitrap XL (Waltham, MA, USA).
3.2. (S)-4-Benzyl-3-(4-(benzyloxy)butanoyl)oxazolidin-2-one (18)
A stirred solution of 16 (1.5 g, 7.7 mmol) in anhydrous THF (38 mL) under argon was cooled to −78 °C for 15 min, and then added with Et3N (2.1 mL, 15.4 mmol) followed by PivCl (1.1 mL, 9.3 mmol). After being stirred for 20 min at −78 °C, the mixture was warmed to room temperature and stirred for 1 h. Solid LiCl (0.66 g, 15.62 mmol) and (S)-4-benzyloxazolidin-2-one (17) (1.4 g, 7.7 mmol) were added at −78 °C. The reaction mixture was stirred for 1 h at −78 °C, slowly warmed to room temperature, and stirred overnight. The reaction was quenched with H2O (10 mL), and the mixture was extracted with ethyl acetate (2 × 10 mL). The combined organic layers were washed with brine (30 mL), dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:5) to give compound 18 as a colorless oil (2.4 g, 89%). 1H NMR (500 MHz, CDCl3) δ 7.34–7.31 (m, 6H), 7.28–7.25 (m, 2H), 7.18 (d, J = 7.1 Hz, 2H), 4.63–4.58 (m, 1H), 4.50 (s, 2H), 4.13–4.08 (m, 2H), 3.58 (t, J = 6.2 Hz, 2H), 3.26 (dd, J = 3.3, 13.4 Hz, 1H), 3.08–3.05 (m, 2H), 2.69 (dd, J = 9.7, 13.4 Hz, 1H), 2.06–2.01 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 173.04, 153.45, 138.44, 135.35, 129.37, 128.91, 128.33, 127.67, 127.53, 127.28, 72.88, 69.23, 66.12, 55.14, 37.87, 32.46, 24.48.
3.3. (S)-4-Benzyl-3-((S)-4-(benzyloxy)-2-methylbutanoyl)oxazolidin-2-one (19)
A stirred solution of 18 (2.4 g, 6.9 mmol) in anhydrous THF (30 mL) at −78 °C under argon was added to a solution of NaHMDS (2.0 M in THF, 6.9 mL, 13.7 mmol). After being stirred at −78 °C for 30 min, MeI (0.83 mL, 13.42 mmol) was added dropwise and then stirring was continued for another 2 h at −78 °C. Then, the reaction was allowed to warm to −50 °C and stirred overnight. The reaction mixture was quenched with saturated NH4Cl solution (10 mL), and the mixture was warmed to room temperature and then extracted with ethyl acetate (2 × 30 mL). The combined organic layers were washed with brine (30 mL), dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:5) to give compound 19 as a colorless oil (1.9 g, 75%). [α]23D = +45.531 (c = 2.6, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.32–7.20 (m, 8H), 7.14 (d, J = 7.0 Hz, 2H), 4.42 (d, J = 2.7 Hz, 2H), 4.0–3.92 (m, 2H), 3.73 (t, J = 8.6 Hz, 1H), 3.59–3.51 (m, 2H), 3.18 (dd, J = 3.3, 13.4 Hz, 1H), 2.7 (dd, J = 9.5, 13.4 Hz, 1H), 2.21–2.14 (m, 1H), 1.77–1.71 (m, 1H), 1.26–1.2 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 177.03, 153.20, 138.50, 135.40, 129.35, 128.78, 128.21, 127.58, 127.46, 127.17, 72.78, 68.43, 65.79, 55.15, 37.95, 35.11, 33.61, 18.01.
3.4. (S)-4-(Benzyloxy)-2-methylbutan-1-ol (20)
A stirred solution of LiAlH4 (2.7 g, 71.4 mmol) in anhydrous THF (55 mL) at 0 °C under argon was added dropwise to a mixture of 19 (5.2 g, 14.3 mmol) and anhydrous THF (40 mL). The reaction mixture was allowed to warm to room temperature, stirred overnight, and quenched with H2O, 10% NaOH solution, andH2O (1:2:3) at 0 °C. The mixture was filtered under reduced pressure and the resulting residue was washed with ethyl acetate. The aqueous layer was extracted with ethyl acetate (2 × 20 mL). The combined organic layers were dried with Na2SO4 and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:10) to afford compound 20 as a colorless oil (2.5 g, 90%). [α]23D = +4.113 (c = 2.3, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.36–7.27 (m, 5H), 4.52 (s, 2H), 3.61–3.57 (m, 1H), 3.55–3.48 (m, 2H), 3.43 (dd, J = 6.6, 10.9 Hz, 1H), 2.62 (s, 1H), 1.85–1.78 (m, 1H), 1.74–1.67 (m, 1H), 1.60–1.54 (m, 1H), 0.92 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 137.99, 128.40, 127.71, 127.67, 73.10, 68.64, 68.03, 34.06, 33.97, 29.65, 17.13.
3.5. (S)-2-(4-(Benzyloxy)-2-methylbutylthi-o) benzo[d]thiazole (22)
A solution of 20 (1.9 g, 10.0 mmol), PPh3 (3.1 g, 12.0 mmol), and 21 in THF (50 mL) was added to DIAD (2.4 mL, 12.0 mmol) at 0 °C. The reaction mixture was allowed to warm to room temperature, stirred for 4 h, and then concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:30) to afford compound 22 as a yellow oil (3.1 g, 90%). [α]23D = +7.305 (c = 3.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.1 Hz, 1H), 7.74 (d, J = 8.0 Hz, 1H), 7.41–7.83 (m, 1H), 7.32–7.27 (m, 6H), 4.51 (d, J = 3.1 Hz, 2H), 3.62–3.54 (m, 2H), 3.46 (dd, J = 5.6, 12.8 Hz, 1H), 3.25 (dd, J = 7.4, 12.9 Hz, 1H), 2.2–2.12 (m, 1H), 1.92–1.85 (m, 1H), 1.65–1.61 (m, 1H), 1.09 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 167.60, 153.32, 138.45, 135.20, 128.41, 127.68, 127.59, 126.02, 124.13, 121.46, 120.94,73.01, 68.13, 40.58, 35.74, 30.70, 19.39.
3.6. (S)-2-(4-(Benzyloxy)-2-methylbutylsulfonyl)benzo[d]thiazole (15)
A solution of 22 (2.7 g, 8.0 mmol) in CH2Cl2 (80 mL) at room temperature was added to m-CPBA (70% purity, 6.9 g, 40.0 mmol). The reaction mixture was stirred at room temperature overnight, quenched with the saturated Na2S2O3 aqueous solution (10 mL), stirred for 10 min, neutralized with the saturated NaHCO3 solution (10 mL), extracted with CH2Cl2 (3 × 10 mL), washed with brine (20 mL), dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:10) to give compound 15 as a yellowish oil (1.9 g, 92%). 1H NMR (500 MHz, CDCl3) δ 8.2 (d, J = 8.3 Hz, 1H), 8.0 (d, J = 7.9 Hz, 1H), 7.65–7.57 (m, 2H), 7.43–7.23 (m, 5H), 4.41 (s, 2H), 3.72 (dd, J = 4.5, 14.4 Hz, 2H), 3.55–3.48 (m, 2H), 3.39 (dd, J = 8.2, 14.4 Hz, 1H), 2.53–2.47 (m, 1H), 1.87–1.8 (m, 1H), 1.69–1.62 (m, 1H), 1.18 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 166.72, 152.74, 138.18, 136.80, 128.40, 128.0, 127.66, 127.62, 125.46, 122.40, 73.0, 67.53, 60.67, 36.21, 26.53, 20.02. HRMS (ESI): m/z calculated for C16H24NO2S2+ (M + H)+: 326.12430; found: 326.12448.
3.7. (S, E)-12-(Benzyloxy)-10-methyldodec-8-enyl isobutyrate (14)
A solution of 15 (0.8 g, 2.1 mmol) in anhydrous THF (25 mL) under argon was added to NaHMDS (2.0 M in THF, 1.6 mL, 3.2 mmol), the reaction mixture was stirred at −78 °C for 30 min, and a solution of 8-oxooctyl isobutyrate 10 (0.7 g, 3.2 mmol) in anhydrous THF (25 mL) was added dropwise. The reaction mixture was stirred at −78 °C for 3 h, slowly warmed to −50 °C, and stirred overnight. The reaction mixture was quenched with a saturated NH4Cl aqueous solution at −50 °C, the mixture was warmed to room temperature, and the aqueous layer was extracted with ethyl acetate (2 × 5 mL), washed with brine (20 mL), dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:200) to give compound 14 as a colorless oil (0.5 g, 63%). (Z/E 3:1 mixture) [α]23D = +3.056 (c = 2.5, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.33–7.25 (m, 5H), 5.36–5.08 (m, 2H), 4.49–4.44 (m, 2H), 4.06–4.03 (m, 2H), 3.49–3.39 (m, 2H), 2.65–2.5 (m, 2H), 2.07–1.93 (m, 2H), 1.7–1.43 (m, 4H), 1.3 (s, 8H), 1.16 (d, J = 7 Hz, 6H), 0.98–0.95 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 177.25, 138.76, 138.73, 135.53, 129.05, 128.34, 127.66, 127.61, 127.47, 72.99, 68.82, 64.4, 37.28, 34.08, 29.85, 29.25, 29.19, 28.68, 28.61, 27.43, 25.93, 25.9, 21.51, 19.05.
3.8. (R)-12-(Benzyloxy)-10-methyldodecyl isobutyrate (23)
A suspension of 10% Pt on carbon (104 mg, 0.5 mmol) and 14 (503 mg, 1.3 mmol) in ethanol (45 mL) were pretreated with hydrogen by five vacuum–hydrogen cycles. The mixture was stirred at room temperature under a hydrogen balloon for 12 h, the catalyst was filtered off, and the solvent was removed under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:50) to give compound 23 as a colorless oil (495 mg, 100%). [α]23D = +1.761 (c = 2.6, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.34–7.26 (m, 5H), 4.5 (s, 2H), 4.05 (t, J = 6.7 Hz, 2H), 3.52–3.47 (m, 2H), 2.57–2.51 (m, 1H), 1.69–1.56 (m, 4H), 1.45–1.38 (m, 1H), 1.33–1.27 (m, 14H), 0.86 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 177.29, 138.76, 128.36, 127.63, 127.48, 72.92, 68.81, 64.43, 37.15, 36.82, 34.09, 29.94, 29.9, 29.61, 29.55, 29.28, 28.69, 26.97, 25.94, 21.51, 19.71, 19.06. HRMS (ESI): m/z calculated for C24H41O3+ (M + H)+: 377.30502; found: 377.30499.
3.9. (R)-12-Hydroxy-10-methyldodecyl isobutyrate (24)
A suspension of 10% Pd on carbon (104 mg, 0.5 mmol) and (R)-12-(benzyloxy)-10-methyldodecyl isobutyrate (23) (503 mg, 1.3 mmol) in ethanol (45 mL) were pretreated with hydrogen by five vacuum–hydrogen cycles. The mixture was stirred at room temperature under a hydrogen balloon for 12 h, the catalyst was filtered off, and the solvent was removed under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:10) to give compound 24 as a colorless oil (495 mg, 99%). 1H NMR (500 MHz, CDCl3) δ 4.06 (t, J = 6.7 Hz, 2H), 3.7–3.65 (m, 2H), 2.53 (td, J = 5, 10 Hz, 1H), 1.63–1.6 (m, 4H), 1.39–1.27 (m, 15H), 1.16 (d, J = 5.0 Hz, 6H), 0.89 (d, J = 5.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 177.31, 64.42, 61.26, 40.0, 37.14, 34.08, 29.88, 29.56, 29.51, 29.5, 29.24, 28.66, 26.94, 25.9, 19.66, 19.03. HRMS (ESI): m/z calculated for C17H35O3+ (M + H)+: 287.25807; found: 287.25818.
3.10. 5-(Isobutylthio)-1-phenyl-1H-tetrazole (27)
A solution of NaH (2.7 g, 83.3 mmol) in DMF (70 mL) at 0 °C was added to a solution of 25 (8.9 g, 83.3mmol) in DMF (30 mL). The reaction mixture was stirred at 0 °C for 10 min, and 26 (5.4 mL, 83.3 mmol) was added and stirred for 12 h. The reaction mixture was quenched with water, extracted with ethyl acetate, washed with brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:5) to give compound 27 as a colorless oil (13.0 g, 98%). 1H NMR (500 MHz, CDCl3) δ 7.64–7.58 (m, 5H), 3.35 (d, J = 6.9 Hz, 2H), 2.18–2.1 (m, 1H), 1.1 (d, J = 6.7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 154.75, 133.8, 130.1, 129.8, 123.93, 41.81, 28.35, 21.74.
3.11. 5-(Isobutylsulfonyl)-1-phenyl-1H-tetrazole (12)
A solution of 27 (12.8 g, 54.2 mmol) in CH2Cl2 (424 mL) was added to NaHCO3 (22.8 g, 270.9 mmol) at room temperature. The reaction mixture was stirred at room temperature for 5 min, and m-CPBA (22.3 g, 90.4 mmol) was added and stirred overnight. The reaction mixture was added to a Na2S2O3 solution (10 mL) and a saturated NaHCO3 aqueous solution (15 mL), stirred for 30 min, extracted with CH2Cl2, washed with brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:5) to give compound 12 as a yellowish oil (10.3 g, 71%). 1H NMR (500 MHz, CDCl3) δ 7.68–7.6 (m, 5H), 3.68 (d, J = 6.6 Hz, 2H), 2.53–2.45 (m, 1H), 1.16 (d, J = 6.8 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 133.13, 131.47, 129.71, 125.18, 63.11, 23.97, 22.55.
3.12. (R, E)-10, 14-Dimethylpentadec-12-enyl isobutyrate (28)
A solution of 12 (269 mg, 1.0 mmol) in anhydrous THF (8 mL) under argon at −78 °C was slowly added to a solution of NaHMDS (2.0 M in THF, 0.5 mL, 1.0 mmol) dropwise. After stirring at −78 °C for 30 min, a solution of 13 (190 mg, 0.7 mmol) in anhydrous THF (8 mL) was added dropwise and stirred for another 2 h at −78 °C. The reaction mixture was allowed to warm to −50 °C and stirred overnight. The reaction mixture was quenched with a saturated NH4Cl solution (5 mL) at −50 °C, and the mixture was warmed to room temperature, extracted with ethyl acetate (2 × 10 mL), washed with brine (10 mL), dried over anhydrous Na2SO4, and concentrated under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:5) to give compound 28 as a colorless oil (213 mg, 98%). [α]23D = +1.997 (c = 2.3, CHCl3). 1H NMR (500 MHz, CDCl3) δ 5.35–5.21 (m, 2H), 4.05 (d, J = 6.8 Hz, 2H), 2.59–2.5 (m, 1H), 2.26–2.22 (m, 1H), 2.04–1.76 (m, 2H), 1.63–1.59 (m, 2H), 1.31–1.25 (m, 15H), 1.16 (d, J = 7 Hz, 6H), 0.95 (dd, J = 6.8, 15 Hz, 6H), 0.84 (dd, J = 6.7, 12.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 177.3, 138.86, 138.17, 126.04, 125.69, 64.44, 40.04, 36.73, 34.64, 34.09, 33.22, 29.93, 29.61, 29.54, 29.27, 28.68, 27.18, 27.07, 26.48, 25,93, 23.18, 23.14, 22.78, 19.05.
3.13. (R)-10, 14-Dimethylpentadecyl isobutyrate ((R)-1)
A suspension of 10% Pd on carbon (13 mg, 0.04 mmol) and 28 (6.5 mg, 0.05 mmol) in ethanol (10 mL) were pretreated with hydrogen using five vacuum–hydrogen cycles. The mixture was stirred under a hydrogen balloon at room temperature for 12 h, the catalyst was filtered off, and the solvent was removed under reduced pressure. The crude product was purified using silica gel (EtOAc/hexane 1:5) to give compound (R)-1 as a colorless oil (13 mg, 100%). [α]23D = +0.581 (c = 2.3, CHCl3). 1H NMR (500 MHz, CDCl3) δ 4.05 (t, J = 6.8 Hz, 2H), 2.56–2.5 (m, 1H), 1.65–1.48 (m, 4H), 1.4–1.19 (m, 17H), 1.16 (d, J = 7 Hz, 6H), 1.15–1.04 (m, 3H), 0.85 (dd, J = 6.6, 13.2 Hz, 9H); 13C NMR δ (125 MHz, CDCl3) 176.08, 63.16, 38.37, 36.32, 36.09, 33.05, 31.76, 28.97, 28.59, 28.51, 28.24, 27.66, 26.97, 26.06, 24.9, 23.79, 21.7, 21.61, 18.7, 18.0. HRMS (ESI): m/z calculated for C21H43O2+ (M + H)+: 327.32576; found: 327.32599.